GREENLAND MINES LTD Diluted Shares Outstanding (Weighted Average)
GREENLAND MINES LTD (GRML) reported Diluted Shares Outstanding (Weighted Average) of 126.52 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-17
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 126.52M shares, a 272.64% increase year-over-year.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 93.73M shares, a 240.54% increase year-over-year.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 72.72M shares, a 167.12% increase year-over-year.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 59.42M shares, a 256.02% increase year-over-year.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for fiscal 2025 was 48.49M shares, a 151.93% increase from fiscal 2024.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for fiscal 2024 was 19.25M shares, a 27.21% increase from fiscal 2023.
- GREENLAND MINES LTD weighted average number of shares outstanding, diluted for fiscal 2023 was 15.13M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 126.52M shares 10-Q · filed 2026-08-17 | 109.95M shares 10-Q · filed 2026-08-17 | 97.66M shares derived: average of 3 quarters · filed 2026-08-17 | 88.10M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | 93.73M shares 10-Q/A · filed 2026-08-14 | 83.22M shares derived: average of 2 quarters · filed 2026-08-14 | 75.29M shares derived: average of 3 quarters · filed 2026-08-14 | 64.95M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | 72.72M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | 66.07M shares derived: average of 2 quarters · filed 2026-08-14 | 55.36M shares derived: average of 3 quarters · filed 2026-08-17 | 48.49M shares 10-K/A · filed 2026-08-14 |
| 2025-09-30 | 59.42M shares 10-Q · filed 2025-11-13 | 46.68M shares derived: average of 2 quarters · filed 2026-08-17 | 40.41M shares 10-Q · filed 2025-11-13 | 37.03M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | 33.95M shares 10-Q · filed 2026-08-17 | 30.76M shares 10-Q · filed 2026-08-17 | 29.57M shares derived: average of 3 quarters · filed 2026-08-17 | 26.35M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | 27.52M shares 10-Q/A · filed 2026-08-14 | 27.37M shares derived: average of 2 quarters · filed 2026-08-14 | 23.81M shares derived: average of 3 quarters · filed 2026-08-14 | 21.78M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2024-12-31 | 27.22M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | 21.96M shares derived: average of 2 quarters · filed 2026-08-14 | 19.86M shares derived: average of 3 quarters · filed 2026-08-14 | 19.25M shares 10-K/A · filed 2026-08-14 |
| 2024-09-30 | 16.69M shares 10-Q · filed 2025-11-13 | 16.18M shares derived: average of 2 quarters · filed 2025-11-13 | 16.59M shares 10-Q · filed 2025-11-13 | 15.66M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 15.68M shares 10-Q · filed 2025-08-18 | 15.68M shares 10-Q · filed 2025-08-18 | 15.31M shares derived: average of 3 quarters · filed 2025-08-18 | 15.27M shares derived: average of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | 15.13M shares 10-Q · filed 2025-05-15 | 15.13M shares derived: average of 2 quarters · filed 2025-05-15 | 15.13M shares derived: average of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | 15.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 15.13M shares derived: average of 2 quarters · filed 2025-03-31 | 15.13M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 15.13M shares 10-Q · filed 2024-11-19 | 15.13M shares 10-Q · filed 2024-11-19 | ||
| 2023-06-30 | 15.13M shares 10-Q · filed 2024-08-19 | |||
| 2022-03-31 | 2.50M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |